Benign essential hypertension
MONDO:0001151A condition of mild to moderate high blood pressure that has no identifiable cause.
15 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New shot aims to lower blood pressure for months
Disease control Recruiting nowThis study tests a single dose of an experimental drug called ALN-AGT01 in adults with mild to moderate high blood pressure who have already been treated with another drug, zilebesiran. The goal is to see if it safely helps control blood pressure by measuring changes in blood pre…
Phase: PHASE2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Couples who sleep together, get healthy together? new study tests sleep program for partners
Disease control Recruiting nowThis pilot study tests whether a sleep health program designed for couples can improve sleep and blood pressure. Fifty couples will take part in an 8-week program that includes sleep education, coaching, and a Fitbit to track sleep. The goal is to see if working together as a tea…
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Arm cuff therapy could replace pills for mild hypertension
Disease control Recruiting nowThis study tests whether a non-invasive technique called remote ischemic preconditioning (RIPC) can help lower blood pressure in people with mild hypertension. RIPC involves briefly restricting blood flow to an arm using a cuff, which may trigger protective effects. Researchers w…
Phase: NA • Sponsor: Henan Institute of Cardiovascular Epidemiology • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Egg white extract could help tame blood sugar and pressure
Symptom relief Recruiting nowThis early study tests whether a peptide called IRW, found in egg white hydrolysate, can help manage high blood sugar and blood pressure. About 28 participants at risk for or with type 2 diabetes will consume a smoothie with the peptide on four separate days, while a healthy cont…
Phase: PHASE1 • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC